CD4 and colonic neoplasm: This is also reflected by the different immune phenotype observed with lower numbers of CD4 single positive cells, CD4 Treg cells, and higher mDC, pDC, NKT cells in therapy-naïve rectal cancer compared to colon cancer (Table S2, Figure 4a), suggesting a lower level of natural immune activation in rectal cancer patients.